Leave no one behind: Optimal Care of all Patients with Haemophilia A.

Abstract

Background: Haemophilia is an inherited bleeding disorder due to failure of throm-bin generation resulting from clotting factor deficiency. In haemophilia A, the de-ficient factor is Factor VIII due to mutations in the F8 gene. In the past several
 decades, we have seen an unprecedented evolution of therapies for managing hae-mophilia A (Mahlangu, 2022) . These have included blood and blood products to
 plasma-derived concentrate, recombinant concentrate, concentrate with improvedpharmacokinetics and, more recently, non-replacement therapies. Notwithstandingthese advances in treatments, patients with haemophilia A (PwHA) remain withseveral unmet needs.